Stocks
Profusa, Inc.PFSA
NASDAQHealthcareMedical Devices$1.01
Price as of · delayed, not real-time
A developer of continuous glucose monitoring systems based on implantable biosensor technology. The company's sensors are designed to provide real-time tissue oxygen and glucose data, positioning it in the emerging market for long-term, in-body diagnostics. Investors track Profusa for its potential to disrupt traditional glucose testing and its progress toward regulatory approval.
52W Range: $0.70-$3000.00
Congressional Interest in Profusa, Inc. (PFSA)
No congressional trades have been disclosed for Profusa, Inc. (PFSA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading PFSA?
No congressional trades found for this stock.